Portal de Periódicos da CAPES

Hepatic encephalopathy in the age of TIPS

1994; Lippincott Williams & Wilkins; Volume: 20; Issue: 1 Linguagem: Inglês

10.1016/0270-9139(94)90160-0

1527-3350

AndresT. Blei,

Liver Disease Diagnosis and Treatment

HepatologyVolume 20, Issue 1 p. 249-252 EditorialFree Access Hepatic encephalopathy in the age of TIPS Andres T. Blei M.D., Corresponding Author Andres T. Blei M.D. Department of Medicine Lakeside Veterans Affairs Medical Center and Northwestern University Chicago, Illinois 60611Lakeside VA Medical Center, Department of Medicine-111E, 333 E. Huron St., Chicago, IL 60611. Hepatology 1994;20:249–252===Search for more papers by this author Andres T. Blei M.D., Corresponding Author Andres T. Blei M.D. Department of Medicine Lakeside Veterans Affairs Medical Center and Northwestern University Chicago, Illinois 60611Lakeside VA Medical Center, Department of Medicine-111E, 333 E. Huron St., Chicago, IL 60611. Hepatology 1994;20:249–252===Search for more papers by this author First published: July 1994 https://doi.org/10.1002/hep.1840200136Citations: 18AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Rocko JM, Swan KG. The Eck-Pavlov connection. Am Surg 1985; 51: 641– 644. 2 Grace ND. The side-to-side shunt revisited. N Engl J Med 1994; 330: 208– 209. 3 Sanyal AJ, Freedman AM, Shiffman ML, Purdum III PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Results of a prospective controlled study. Hepatology 1994; 20: 46– 55. 4 Laberge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187: 413– 420. 5 Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992; 116: 304– 309. 6 Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, Berger E, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165– 171. 7 Sanyal AJ, Freedman AM, Purdum PP, Luketic VA, Shiffman ML, Tisnado J, Cole P. Transjugular intrahepatic portosystemic shunt (TIPS) vs. sclerotherapy for prevention of recurrent variceal hemorrhage: a randomized prospective trial [Abstract]. Gastroenterology 1994; 106: A975. 8 Mutchnick MG, Lerner E, Conn HO. Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenterology 1974; 67: 1005– 1019. 9 Rypins EB, Sarfeh IJ. Small-diameter portacaval H-graft for variceal hemorrhage. Surg Clin North Am 1990; 70: 395– 404. 10 Johansen K. Prospective comparison of partial versus total portal decompression for bleeding esophageal varices. Surg Gynecol Obstet 1992; 175: 528– 534. 11 Rikkers LF. Portal hemodynamics, intestinal absorption, and post-shunt encephalopathy. Surgery 1983; 94: 126– 133. 12 Coy DL, Srivastava A, Gottstein J, Butterworth RF, Blei AT. Postoperative course after portacaval anastomosis in rats is determined by the portacaval pressure gradient. Am J Physiol 1991; 261: G1072– G1078. 13 Huet P-M, Marleau D, Viallet A, Duguay L, Tanguay S, Lavoie P. Symposium on portal hypertension and its complications: current management, preoperative assessment and predictors of encephalopathy. Can J Surg 1979; 22: 545– 548. 14 Pomier-Layrargues G, Huet P-M, Infante-Rivard C, Villeneuve JP, Marleau D, Duguay L, Tanquay S, et al. Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt. Hepatology 1988; 8: 1506– 1510. 15 Planas R, Gomes-Vieira MC, Cabre E, Armengol M, Guer JC, Boix J, Morillos R, et al. Prognostic factors of hepatic encephalopathy after portacaval anastomosis: a multivariate analysis in 50 patients. Am J Gastroenterol 1992; 87: 1792– 1796. 16 Somberg KA, Riegler JL, Doherty M, LaBerge JM, Bacchetti P, Roberts JP, Lake JR. Hepatic encephalopathy following transjugular intrahepatic portosystemic shunts (TIPS): incidence and risk factors [Abstract]. Hepatology 1992; 16: 122A. 17 Conjeevaram HS, Mullen KD, May EJ, McCullough AJ. Genderdependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt. Hepatology 1994; 19: 381– 388. 18 Jones EA, Skolnick P, Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy. Prog Liver Dis 1990; 9: 345– 370. 19 Butterworth RF. Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 1992; 37: 321– 327. 20 Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology 1992; 15: 449– 453. 21 Peterson C, Giguere JF, Cotman CW, Butterworth RF. Selective loss of N-methyl-d-aspartate-sensitive l-[3H]glutamate binding sites in rat brain following portacaval anastomosis. J Neurochem 1990; 55: 386– 390. 22 Hawkins RA, Jessy J. Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis. Biochem J 1991; 277: 697– 703. 23 Pomier-Layrargues G, Giguere JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, et al. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology 1994; 19: 32– 37. 24 Mullen KD, Basile AS. Benzodiazepine-receptor antagonists and hepatic encephalopathy: where do we stand? Gastroenterology 1993; 105: 937– 940. 25 Rothstein JD. Benzodiazepine-receptor ligands and hepatic encephalopathy: a causal relationship? Hepatology 1994; 19: 248– 250. 26 Coy DL, Mehta R, Zee P, Salchli F, Turek FW, Blei AT. Portal-systemic shunting and the disruption of circadian locomotor activity in the rat. Gastroenterology 1992; 103: 222– 228. 27 Conjeevaram HS, Nagle A, Katz A, Kaminsky-Russ K, McCullough AJ, Mullen KD. Reversal of behavioral changes in the portacaval shunt rat with oral neomycin therapy. Hepatology 1994; 19: 1245– 1250. 28 Kreis R, Farrow N, Ross BD. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991; 4: 109– 116. 29 Lockwood AH, Murphy BW, Donnelly KZ, Mahl TC, Perini S. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 1993; 18: 1061– 1068. 30 Zimmon DS, Kessler RE. Hepatic hemodynamic factors reflect prognosis after portocaval shunting. Gastroenterology 1973; 64: 166– 170. 31 Sushma S, Dassarathy S, Tandon RK, Jain S, Gupta S, Bhist MS. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology 1992; 16: 138– 144. 32 Olafsson S, Brusilow SW, Blei AT. Phenyl-butyrate therapy in cirrhotic patients with hyperammonemia [Abstract]. Hepatogastroenterology 1993; 40(suppl): 69. 33 Bianchi GP, Marchesini G, Fabri A, Rondelli A, Bugianesi E, Zoli M, Pisi E. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med 1993; 233: 385– 392. Citing Literature Volume20, Issue1July 1994Pages 249-252 ReferencesRelatedInformation